• Nenhum resultado encontrado

Association between the IL1B (-511), IL1B (+3954), IL1RN (VNTR) polymorphisms and Graves' disease risk: a meta-analysis of 11 case-control studies.

N/A
N/A
Protected

Academic year: 2017

Share "Association between the IL1B (-511), IL1B (+3954), IL1RN (VNTR) polymorphisms and Graves' disease risk: a meta-analysis of 11 case-control studies."

Copied!
7
0
0

Texto

Loading

Imagem

Figure 1 summarized the process of identifying eligible studies.
Table 2. Genotype distribution of IL-1 polymorphisms in patients and controls.
Table 3 showed between-study heterogeneity in details. Begg’s test was used to evaluate publication bias
Table 3. Meta-analysis of polymorphisms in the IL-1 gene and GD risk.
+2

Referências

Documentos relacionados

In order to better understand the genetic role of PDE4B for schizophrenia sus- ceptibility, we recapitulated the association of different PDE4B SNPs with schizophrenia risk

The inclusion criteria for the gene association studies in this meta-analysis were as follows: (1) independently published case-control studies explored the association between

Although the association in this study suggested a modest risk of 20% for both-819T and -592A alleles in leprosy susceptibility, these results support the role of these polymorphisms

Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta- analysis.. Cancer

Conclusions/Significance: This meta-analysis indicates that ADPRT Val762Ala and APE1 Asp148Glu polymorphisms are not associated with increased breast cancer risk.. Citation: Wu B,

This meta- analysis explored the association between the CYP1A1 exon7 gene polymorphisms and lung cancer risk, and performed the subgroup analysis stratified by ethnicity,

Studies were included in the meta-analysis if they met the following criteria: (1) the study as- sessed the association between hepatocellular carcinoma risk and COX-2

Considering the relatively small sample size in each single study might have low power to detect the effect of the polymorphisms on cancer risk and the underlying heterogeneity